Clesrovimab offers single-dose RSV protection for infants in first season
A single 105 mg dose of the long-acting antibody clesrovimab, recently approved in the USA and EU, provides durable protection ...
Tag: lower respiratory tract disease
POPULAR NEWS
-
Rumpelstiltskin Protein Guards Genome Boundaries in Fruit Flies
-
Carbon Monoxide Clears Slower Than Expected: Oxygen Therapy Half-Life Falters Over Time
-
Blood markers of neutrophil traps differ across four inflammatory skin diseases
-
Oyster Gene Marker for Herpesvirus Resistance Offers No Shield Against Bacterial Pathogen